SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-025979
Filing Date
2018-11-01
Accepted
2018-11-01 06:36:44
Documents
62
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amrn-10q_20180930.htm 10-Q 1929360
2 EX-31.1 amrn-ex311_8.htm EX-31.1 16357
3 EX-31.2 amrn-ex312_6.htm EX-31.2 16760
4 EX-32.1 amrn-ex321_7.htm EX-32.1 9910
  Complete submission text file 0001564590-18-025979.txt   7218766

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT amrn-20180930.xml EX-101.INS 1473871
6 XBRL TAXONOMY EXTENSION SCHEMA amrn-20180930.xsd EX-101.SCH 58194
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE amrn-20180930_cal.xml EX-101.CAL 41385
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amrn-20180930_def.xml EX-101.DEF 232395
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20180930_lab.xml EX-101.LAB 445962
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20180930_pre.xml EX-101.PRE 355058
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21392 | Film No.: 181151913
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences